NATRNature's Sunshine Products, Inc.

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

On August 6, Nature’s Sunshine Products (NASDAQ:NATR) held its second-quarter earnings call, and the numbers told two very different stories at once. Net sales hit $117 million, the strongest second quarter in the company’s history. Gross margin climbed to 73.7%, the highest level in over four years. Yet management also cut its full-year sales and […]

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Nature's Sunshine Products (NASDAQ:NATR) outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company’s prim

Nature’s Sunshine’s second quarter was met with a significant negative market reaction following results that missed Wall Street’s revenue and non-GAAP profit expectations. Management attributed the quarter’s growth to strong digital channel expansion, particularly in North America and Asia Pacific, and highlighted a 26% increase in digital sales. CEO Ken Romanzi pointed to ongoing investments in digital tools, consultant engagement, and new customer acquisition as key drivers, while acknowledgi

CEO outlines $1 billion revenue target amid China headwinds and digital expansion gains.

Wellness products company Nature’s Sunshine (NASDAQ:NATR) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.9% year on year to $117 million. The company’s full-year revenue guidance of $495 million at the midpoint came in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.21 per share was 22.2% below analysts’ consensus estimates.

Shares of wellness products company Nature’s Sunshine (NASDAQ:NATR) fell 17.7% in the afternoon session after the company reported second-quarter 2026 results that missed Wall Street's expectations and lowered its full-year revenue forecast. The wellness products company's revenue of $117 million came in 5.4% below analyst estimates, while its adjusted earnings per share of $0.21 missed by a wider margin of 22.2%. Compounding the weak quarterly performance, Nature's Sunshine also cut its full-ye

Moby summary of Nature's Sunshine Products, Inc.'s Q2 2026 earnings call

Natures Sunshine Products Inc (NATR) posts strongest Q2 ever with 4% constant currency growth, but lowers full-year guidance due to FX and China weakness.

Nature's Sunshine Products (NASDAQ:NATR) reported second-quarter net sales of $117 million, its strongest second quarter in company history, as digital growth in North America and continued momentum across much of Asia-Pacific and Europe supported results. Sales increased 2% from the prior-year qua

Wellness products company Nature’s Sunshine (NASDAQ:NATR) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.9% year on year to $117 million. The company’s full-year revenue guidance of $495 million at the midpoint came in 2.5% below analysts’ estimates. Its non-GAAP profit of $0.21 per share was 22.2% below analysts’ consensus estimates.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.